Profile data is unavailable for this security.
About the company
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
- Revenue in CHF (TTM)6.72bn
- Net income in CHF654.00m
- Incorporated2002
- Employees18.00k
- LocationLonza Group AGMuenchensteinerstrasse 38BASEL 4002SwitzerlandCHE
- Phone+41 613168111
- Fax+41 613169111
- Websitehttps://www.lonza.com/
Mergers & acquisitions
| Acquired company | LONN:SWX since announced | Transaction value |
|---|---|---|
| Genentech Inc-Biologics Manufacturing Facility,Vacaville,California | 1.00% | 1.20bn |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| argenx SE | 1.27bn | -295.74m | 19.79bn | 1.15k | -- | -- | -- | 15.58 | -5.22 | -5.22 | 22.42 | -- | -- | -- | -- | 1,131,473.00 | -- | -17.65 | -- | -19.79 | 89.87 | -- | -23.28 | -97.72 | -- | -- | -- | -- | 198.56 | 117.25 | 58.42 | -- | 122.32 | -- |
| UCB SA | 5.14bn | 335.51m | 24.48bn | 9.08k | 73.07 | 2.72 | 24.20 | 4.76 | 1.76 | 1.76 | 26.91 | 47.30 | 0.3345 | 1.76 | 4.63 | 578,223.10 | 2.18 | 5.03 | 2.67 | 6.28 | 67.50 | 72.21 | 6.53 | 12.66 | 0.9224 | 3.14 | 0.2530 | 36.44 | -4.80 | 2.54 | -18.33 | -15.41 | -1.51 | 2.36 |
| Bayer AG | 45.99bn | -3.05bn | 27.14bn | 98.19k | -- | 0.7792 | 3.79 | 0.5901 | -3.17 | -3.17 | 47.85 | 36.24 | 0.3839 | 1.44 | 3.27 | 471,435.90 | -2.55 | -1.79 | -3.48 | -2.38 | 58.57 | 59.02 | -6.64 | -4.80 | 0.8727 | 3.16 | 0.564 | -- | -6.11 | 5.33 | -170.87 | -- | 1.19 | -47.66 |
| Haleon PLC | 12.91bn | 1.24bn | 34.13bn | 24.00k | 27.82 | -- | 157.92 | 2.64 | 0.1168 | 0.1168 | 1.21 | -- | -- | -- | -- | 468,125.00 | -- | -- | -- | -- | 61.71 | -- | 10.12 | -- | -- | 7.27 | -- | -- | 4.09 | -- | -1.04 | -- | -- | -- |
| Lonza Group AG | 6.72bn | 654.00m | 36.22bn | 18.00k | 54.86 | 3.71 | 29.47 | 5.39 | 8.87 | 8.87 | 91.16 | 131.07 | 0.3928 | 2.80 | 5.84 | 373,166.70 | 3.83 | 5.07 | 4.64 | 6.21 | 29.00 | 39.15 | 9.75 | 14.52 | 1.20 | 11.86 | 0.2275 | 30.57 | 7.94 | 3.92 | -46.17 | -0.0306 | 23.95 | 7.78 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 2.57m | 3.45% |
| Norges Bank Investment Managementas of 12 Apr 2024 | 2.23m | 2.99% |
| UBS Asset Management Switzerland AGas of 07 May 2024 | 1.81m | 2.43% |
| BlackRock Fund Advisorsas of 09 May 2024 | 1.20m | 1.62% |
| Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024 | 1.11m | 1.48% |
| BlackRock Investment Management (UK) Ltd.as of 30 May 2024 | 937.90k | 1.26% |
| Invesco Advisers, Inc.as of 30 Apr 2024 | 901.87k | 1.21% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 850.00k | 1.14% |
| Schroder Investment Management Ltd.as of 30 Apr 2024 | 841.51k | 1.13% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 823.70k | 1.11% |
